Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 60 filings·Updated 25 Aug 2026
Showing 10 of 60 filings.
25 Aug 20261 filing
Company UpdateGeneral

CRISIL ESG Rating of 61 (Strong) assigned to EID Parry for FY2025-26

ESG rating update

  • CRISIL ESG Ratings independently assigned a score of 61 (Strong) for FY2025-26.
  • The company did not engage CRISIL; rating based on public-domain information.
  • Rating submitted to BSE and NSE on 24 August 2026 at 8:07 p.m.
Filed 11:44View Source
19 Aug 20261 filing
Company UpdateEarnings Call Transcript

EID Parry Q1 FY27: CPG breakeven in 4–5 quarters; Nutra margins improve; PSRIPL closure progressing

Financial Performance

  • Consolidated turnover Rs 61 crores in Q1 FY27 vs Rs 27 crores prior year
  • Sugar segment revenue Rs 410 crores in Q1 vs Rs 347 crores prior year
  • CPG turnover Rs 94 crores vs Rs 188 crores prior year
  • Nutra turnover Rs 6.22 crores vs Rs 6 crores prior year
  • Tamil Nadu sugar unit: 54 days; cane 1.47 LMT; gross recovery 7.95%
  • Sugar sales 0.89 LMT; avg price Rs 40.02/kg; closing stock 1.1 LMT
  • Closing stock valued ~ Rs 42 per kg; 1.1 LMT vs 1.2 LMT prior year
  • Consolidated revenue drivers: higher sugar volume; FRPs paid on time
  • Co-gen: 180 LU generated; power exports 89 LU; tariff Rs 4.89/unit
  • Power segment revenue Rs 6.6 crores; prior year Rs 7.53 crores
  • Distillery: 351 lakh liters produced; 380 lakh liters sold; ENA 138, Ethanol 242
  • Distillery price realization Rs 63.49 per liter vs Rs 67.59 prior year
  • Nutra consolidated turnover Rs 6.22 crores; prior year Rs 6 crores
  • CPG and Nutra margin trajectory discussed separately in Q&A
  • PSRIPL refinery closure: bank liabilities fully settled; denotification in progress
  • PSRIPL SEZ exit: in-principle letter received; close by Sep 30, 2026
  • Rs 610 crores infused into PSRIPL to settle bank obligations; fully closed
  • Additional Rs 55 crores loan; total infusion Rs 665 crores; Rs 65 crores left if needed
  • Standalone debt as of 30-Jun: short-term Rs 980 crores; long-term Rs 150 crores

Segment Update

  • Jaggery and brown sugar: margins substantially better than white sugar
  • Jaggery turnover target around Rs 100 crores from both plants when online
  • Nutra: growth driven by Valensa; derm/skin products contributing
  • US Nutra growth; India share ~20%; Europe certification issues resolved
  • CPG: 4–5 quarter path to quarterly breakeven; new products like jaggery, brown sugar
  • TN/AP cane supply constrained; Karnataka yields critical in H2 to support crushing

Balance Sheet and Cash Flow

  • Inventory 1.16 LMT; valued at Rs 41.50 per kg
  • PSRIPL: 610 crores infused to settle bank liabilities; liquidation of assets underway
  • Total infusion in quarter about Rs 665 crores; Rs 65 crores left if required
  • PSRIPL closing date: Sept 30, 2026; SEZ denotification subject to approvals
  • No outstanding bank dues on PSRIPL; SEZ exit in progress

Projects and Capex

  • PSRIPL refinery operations ceased as of 31-Mar-2026; no ongoing operations
  • Non-core land disposals planned; FY27 timeline for monetization
  • Ethanol capacity: 582 KLPD; grain capacity 120 KLPD; primary focus on margins
  • Jaggery plants expected to contribute meaningfully on turnover once online

Guidance and Outlook

  • CPG breakeven targeted in 4–5 quarters; margin accretive mix
  • Nutra EBITDA margin steady-state at 12–15% (healthy trajectory expected)
  • Working capital efficiency; reduce debt cost; monetize NPAs
  • Strengthen balance sheet by March-27 and March-28

Q&A Highlights

  • Sanjay Shah: CPG breakeven timeline; jaggery plant turnover target; organic vs inorganic growth
  • Muthiah: CPG revenue down; margins improved; breakeven path 4–5 quarters; exploring organic/inorganic options
  • Venkat: Nutra scale drives higher revenue; margin target 12–15% steady-state
  • Gautam: Nutra scale notched; India Nutra ~20% of turnover; US drive critical
  • Rajesh: Tamil Nadu cane supply and potential 5% year-on-year impact; Karnataka as hedge
  • Abdul Hakeem: TN cane incentive direct to farmers; no working-capital impact; pre-draw analyzed on maturity
  • Sanjay Manyal: Ethanol vs sugar tradeoffs; OMC commitment penalties; capacity 582 KLPD
Filed 11:10View Source
18 Aug 20262 filings
Company UpdateNewspaper Publication

Newspaper Publication

Filed 16:21View Source
Company UpdateCopy of Newspaper Publication

EID Parry India Limited has informed the Exchange about Copy of Newspaper Publication

Filed 16:20View Source
14 Aug 20261 filing
AGM/EGMAGM

EID-Parry AGM approves standalone and consolidated financials, asset disposal by subsidiary, and cost auditor remuneration

AGM Details

  • AGM held on 12 August 2026 at 3:00 PM IST via video conferencing.
  • End time of the meeting was 4:12 PM IST.
  • Record date was 05 August 2026.
  • Last date for receipt of postal ballot forms was 12 August 2026.

Resolutions Put to Vote

  • Item 1 involved adoption of the standalone financial statements and related reports.
  • Item 2 involved adoption of the consolidated financial statements.
  • Item 3 involved re-appointment of MM Venkatachalam, (DIN 00152619).
  • Item 4 involved approval of disposal of assets of the material subsidiary Parry Sugars Refinery India Private Limited.
  • Item 5 involved ratification of remuneration payable to Cost Auditor for FY 2027.

Voting Outcomes

  • Item 1 passed; in favour ~99.999%, against ~0.001%.
  • Item 2 passed; in favour ~99.999%, against ~0.001%.
  • Item 3 passed; in favour 98.681%, against 1.319%.
  • Item 4 passed as a special resolution; in favour 77.696%, against 22.304%.
  • Item 5 passed; in favour ~99.999%, against ~0.001%.

Director Changes

  • Reappointment of MM Venkatachalam as director liable to retire by rotation.

Auditors & Remuneration

  • Remuneration for Cost Auditor for FY2027 ratified.

Material Related Party Transactions

  • Approval for disposal of assets by the material subsidiary Parry Sugars Refinery India Private Limited.
Filed 15:51View Source
13 Aug 20263 filings
Company UpdateAnalyst / Investor Meet

No meeting details provided in analyst/investor meet filing for EID Parry India Ltd

No meeting details provided in analyst/investor meet filing for EID Parry India Ltd

Filed 15:55View Source
Company UpdateNewspaper Publication

Newspaper Publication

Filed 15:49View Source
Company UpdateCopy of Newspaper Publication

EID Parry India Limited has informed the Exchange about Copy of Newspaper Publication

Filed 15:48View Source
12 Aug 20262 filings
AGM/EGMAGM

EID Parry India 51st AGM via VC approves financials, director rotation, and subsidiary asset disposal

AGM details

  • AGM held on 12 August 2026 at 3:00 p.m. IST via VC/OAVM.
  • e-voting remained open during the AGM and closed after counting.
  • AGM concluded at 4:12 p.m.

Key resolutions

  • Adoption of standalone financial statements for FY ended 31 March 2026 (Ordinary).
  • Adoption of consolidated financial statements for FY ended 31 March 2026 (Ordinary).
  • Re-appointment of Mr. M. M. Venkatachalam as Director liable to retire by rotation (Ordinary).
  • Special Resolution: disposal of assets of Parry Sugars Refinery India Private Limited (material subsidiary).
  • Ordinary Resolution: ratification of remuneration payable to Cost Auditors.

Voting results

  • Voting results to be submitted by the Scrutinizer and uploaded on company and exchange portals.

Director changes

  • Re-appointment of Mr. M. M. Venkatachalam as Director liable to retire by rotation.

Auditors

  • Remuneration payable to Cost Auditors ratified.

Material approvals / related party

  • Approval for disposal of assets of the material subsidiary.
Filed 19:11View Source
ResultFinancial Results

EID Parry Q1 FY27: Consolidated revenue ₹9,017 cr; EBITDA ₹781 cr; PAT ₹142 cr; PSRIPL impairment impact

Financial performance

  • Consolidated revenue from operations: ₹9,017 crore for quarter ended Jun 30, 2026.
  • Consolidated EBITDA: ₹781 crore; year-ago quarter: ₹895 crore.
  • Consolidated PAT: ₹142 crore vs ₹246 crore in the prior-year quarter.
  • Standalone revenue: ₹733 crore; standalone EBITDA loss ₹23 crore; standalone PAT loss ₹89 crore.
  • Aged receivables provision ₹4,537 lakh against Parry International FZCO exposure.
  • PSRIPL impairment/closure impact: ₹61,000 lakh invested; ₹5,500 lakh disbursed in quarter.

Segment performance

  • Sugar revenue: ₹410 crore in Q1 FY27, up 18% YoY from ₹347 crore.
  • Distillery revenue: ₹255 crore; down from ₹296 crore due to ENA quota effects.
  • Co-generation revenue: ₹7 crore; down from ₹8 crore.
  • Nutraceuticals revenue: ₹61 crore; near-zero segment profit.
  • Consumer Products revenue: ₹94 crore; down from ₹187 crore.
  • Intersegmental revenue: ₹(39) crore; revenue from operations: ₹788 crore.
  • Sugar PBT: loss ₹49 crore; Distillery PBT: ₹9 crore; Co-generation PBT: loss ₹22 crore; Consumer Products PBT: loss ₹12 crore; Nutraceuticals: near-zero.

Capex, capacity & operations

  • Sugar capacity: 40,800 TCD; power 140 MW; distillery 582 KLPD.
  • Six sugar plants and one standalone distillery across three states.
  • Jaggery facility in Karnataka under construction; commissioning targeted by FY27 Q3.
  • PSRIPL closure completed; operations ceased 31 Mar 2026; liquidation underway.
  • Positive free cash flow in the quarter; working capital management improved.

Outlook & guidance

  • Focus on disciplined renewal to strengthen core Sugar and Biofuels.
  • Digital capabilities and brand equity acceleration; premiumization in Consumer Products.
  • Jaggery facility commissioning expected by FY27 Q3; ongoing asset rationalization and efficiency programs.

Risks / headwinds

  • Headwinds include lower ENA quotas in Tamil Nadu and adverse weather affecting cane.
  • Higher input costs and currency/regulatory pressures could affect margins.
  • Liqidity and working-capital management remain critical amid ongoing asset closures.

Business model & segments

  • Operations span Sugar, Co-generation, Distillery, Nutraceuticals, and Consumer Products.
  • Murugappa Group parent; 100% stake in Parry Sugars Refinery India Private Limited; US Nutraceuticals Inc.
  • PSRIPL and related subsidiaries form key elements of the group’s diversification.
Filed 14:15View Source
Showing 10 of 60 filings